LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Antibiotic Resistant Bacteria Succumb to Treatment with Unique Natural Clay

By LabMedica International staff writers
Posted on 07 Feb 2016
Image: Naturally occurring clay from Kisameet Bay, Canada, exhibits potent antibacterial activity against multidrug-resistant pathogens (Photo courtesy of Kisameet Glacial Clay Inc.).
Image: Naturally occurring clay from Kisameet Bay, Canada, exhibits potent antibacterial activity against multidrug-resistant pathogens (Photo courtesy of Kisameet Glacial Clay Inc.).
A team of Canadian medical microbiologists has demonstrated the potential use of a unique type of natural clay for treating pathogenic bacteria that have become resistant to the commonly used antibiotics.

Medicinal and therapeutic use of mineral products has impacted human health for thousands of years, and pure clay minerals, such as smectite and illite, are nanomaterials of geological origin. The intentional consumption of earth materials, such as clays, by humans and animals is known as geophagy, a complex behavior, largely attributed to religious beliefs, cultural practices, psychological disorders, cosmetics, dietary/nutritional needs, and medicinal benefits. Early research focused on the extraordinary adsorptive properties of clay minerals and the health benefits recognized in aiding digestive processes and cleansing and protecting the skin. Due to the small particle size (less than two micrometers), these natural geological products have a vast surface area (hundreds of square meters per gram of clay) with high concentrations of ions and compounds located on the surfaces. Despite the clear, beneficial effects on human health related to ridding the body of foreign substances, few studies have investigated the antibacterial properties of clay minerals.

Investigators at the University of British Columbia (Canada) worked with Kisameet clay, which was found in a shallow five-acre granite basin located about 400 kilometers north of Vancouver, Canada. This material was valued by indigenous peoples for its therapeutic properties for treatment of a wide variety of disorders including ulcerative colitis, duodenal ulcer, arthritis, neuritis, phlebitis, skin irritation, and burns.

In particular the investigators examined the effect of the clay on the bacteria comprising the ESKAPE group (Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which have developed antibiotic resistance and cause the majority of nosocomial infections.

They reported in the January 26, 2016, online edition of the journal mBio that in vitro tests of the clay suspended in water showed that it was capable of killed 16 strains of ESKAPE bacteria from various sources.

"Infections caused by ESKAPE bacteria are essentially untreatable and contribute to increasing mortality in hospitals," said senior author Dr. Julian Davies, professor emeritus in microbiology at the University of British Columbia. "After 50 years of over-using and misusing antibiotics, ancient medicinals and other natural mineral-based agents may provide new weapons in the battle against multidrug-resistant pathogens."

Related Links:

University of British Columbia


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more